Publication
Number of items: 11.
1 July 2024
  • Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters. (2024) Diana A Gorog
  • 14 May 2023
  • Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction. (2023) Seung Hun Lee, Hyun Kuk Kim, Jong-Hwa Ahn, Min Gyu Kang, Kye-Hwan Kim, Jae Seok Bae, Sang Young Cho, Jin-Sin Koh, Yongwhi Park, Seok Jae Hwang, Diana Gorog, Udaya S. Tantry, Kevin P. Bliden, Paul A Gurbel, Jin-Yong Hwang and Young-Hoon Jeong
  • 1 October 2021
  • When a meta-analysis equals a single large-scale trial with meaningful follow-up. (2021) Eliano P Navarese, Dean Kereiakes, Diana Gorog, Alexandra Lansky and Felicita Andreotti
  • 29 July 2021
  • Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention? (2021) Diana Gorog, Eliano P Navarese and Felicita Andreotti
  • 18 May 2021
  • Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: A systematic review and meta-analysis. (2021) Eliano P Navarese, Alexandra Lansky, Dean Kereiakes, Jacek Kubica, Paul A Gurbel, Diana Gorog, Marco Valgimigli, Nick Curzen, David. E. Kandzari, Marc Bonaca, Marc Brouwer, Julia M UmiƄska, Milosz Jaguszewski, Paolo Raggi, Ron Waksman, Martin B. Leon, William Wijns and Felicita Andreotti
  • 25 March 2021
  • Antithrombotic therapy in diabetes: Which, when, and for how long? (2021) RA Ajjan, N Kietsiriroje, L Badimon, Diana Gorog, Dominick J. Angiolillo, D Russel, Bianca Rocca and Robert F. Storey
  • 1 September 2020
  • Low-grade endotoxemia and platelets: a deadly aggregation. (2020) Luca Liberale and Diana Gorog
  • Low-grade endotoxaemia and platelets : A deadly aggregation. (2020) Luca Liberale and Diana A. Gorog
  • Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes. (2020) Robert F. Storey, Paul A. Gurbel, Jurrien ten Berg, Corine Bernaud, George D. Dangas, Jean Marie Frenoux, Diana A. Gorog, Abdel Hmissi, Vijay Kunadian, Stefan K. James, Jean Francois Tanguay, Henry Tran, Dietmar Trenk, Mike Ufer, Pim van der Harst, Arnoud W.J. Van't Hof and Dominick J. Angiolillo
  • 20 July 2020
  • Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19. (2020) Ying Gue and Diana Gorog
  • 14 January 2019
  • Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events : the RISK PPCI study. (2019) Mohamed Farag, Nikolaos Spinthakis, Ying X. Gue, Manivannan Srinivasan, Keith Sullivan, David Wellsted and Diana A. Gorog